Every open market buy and sale of Neurocrine Biosciences Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $79.9M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when NBIX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an NBIX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every NBIX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Gary A LyonsDirector | Sale plan | 15,000 | $164.87 | $2.5M | 122,141 | Nov 19Form 4 |
| Nov 3, 2026 | George J MorrowDirector | Sale plan | 15,000 | $155.73 | $2.3M | 10,386 | Nov 3Form 4 |
| Sep 14, 2026 | Matt AbernethyCFO | Sale plan | 2,311 | $157.20 | $363K | 42,808 | Sep 15Form 4 |
| Sep 14, 2026 | David W. BoyerChief Corp. Affairs Officer | Sale plan | 826 | $157.45 | $130K | 8,722 | Sep 15Form 4 |
| Sep 9, 2026 | Eric BenevichChief Commercial Officer | Sale plan | 2,154 | $154.61 | $333K | 64,408 | Sep 10Form 4 |
| Jul 28, 2026 | Leslie V NorwalkDirector | Sale plan | 1,250 | $182.01 | $228K | 1,588 | Jul 30Form 4 |
| Jul 10, 2026 | Ingrid DelaetChief Regulatory Officer | Sale plan | 4,367 | $181.02 | $791K | 16,225 | Jul 13Form 4 |
| Jul 9, 2026 | Darin LippoldtChief Legal Officer | Sale plan | 10,000 | $179.60 | $1.8M | 54,729 | Jul 13Form 4 |
| Jul 9, 2026 | Ingrid DelaetChief Regulatory Officer | Sale plan | 14,571 | $178.65 | $2.6M | 16,225 | Jul 9Form 4 |
| Jun 29, 2026 | Darin LippoldtChief Legal Officer | Sale plan | 10,000 | $170.15 | $1.7M | 54,729 | Jun 30Form 4 |
| Jun 5, 2026 | Stephen A SherwinDirector | Sale plan | 25,000 | $165.32 | $4.1M | 15,860 | Jun 9Form 4 |
| Jun 4, 2026 | Leslie V NorwalkDirector | Sale plan | 1,250 | $168.06 | $210K | 2,838 | Jun 8Form 4 |
| Jun 2, 2026 | Julie CookeChief Human Resources Officer | Sale plan | 36,937 | $156.22 | $5.8M | 22,374 | Jun 4Form 4 |
| Jun 1, 2026 | Jude OnyiaChief Scientific Officer | Sale plan | 11,000 | $160.25 | $1.8M | 25,846 | Jun 2Form 4 |
| May 29, 2026 | Ingrid DelaetChief Regulatory Officer | Sale plan | 2,261 | $156.71 | $354K | 16,225 | Jun 2Form 4 |
NBIX insider trading FAQ
Are NBIX insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of NBIX on the open market in 0 trades, and 14 sold $79.9M in 26 trades, 100% of that under pre-arranged trading plans.
When did an NBIX insider last buy shares?
There has been no open market insider purchase of NBIX in the last two years.
When did an NBIX insider last sell shares?
Gary A Lyons (Director) sold 15,000 shares for $2.5M on Nov 17, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
